Last year we submitted one NDA and one PMA. One of our clients submitted a BLA. These submissions used Target e*CRF® as the EDC tool for the pivotal trials. Already this year we have submitted one IND and a 2nd IND is going in this week. One of our clients is submitting an NDA this quarter which also used Target e*CRF® as the EDC tool for all of the clinical trials. We now also represent over 25 companies at FDA. Our regulatory group is headed by Dr. Glen Park with a strong team including: Mary Shatzoff, Fredy Varela, Daisy Sun, and Carlos Figueroa.

For more information, please contact Dr. Jules T. Mitchel or Joyce Hays. For new business opportunities, contact Dr. Jules T. Mitchel

Comments

Leave a Reply

You must be logged in to post a comment.